Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
EXECUTIVE SUMMARY
CHALLENEGS FOR INDIAN TECHNOLOGY INNOVATORS THE BASIS OF A STRUCTURED APPROACH TO INNOVATION THE FOUR FACES OF AN INNOVATOR: BSKV MODEL THE FOUR RELIABLE METRICS TO MEASURE INNOVATION PROGRESS INNOVATION FLOW SCAMMPER TOOL THE OPEN INNOVATION MODEL CURRENT GLOBAL INITIATIVES FOR OPEN INNOVATION OPEN INNOVATION IN INDIA
WHAT HOW
THE POOR CONEVRSION OF GREAT IDEAS INTO VALUABLE INNOVATION FAILURE OF TRANSFORMING IDEA TO INNOVATION CAUSES DISAPPOINTMENT OF ALL STAKEHOLDERS NEW PRODUCT DEVELOPMENT FALLS INTO COMA GOVERNMENT LABORATIES TO SMALL TECHNOLOGY START-UPS. WHEN MARKET IS AHEAD OF THE TECHNLOGY AND VICEVERSA MOST EMERGING ECONOMIES MOST DO NOT REALISE IMPORTANCE OF MONETIZING VALUABLE IP NO EFFECTIVE USE OF TECHNOLOGY TO BRING ABOUT DIFFERENTIATION
Insightful Idea
Observation Questioning Incubating Associating Experimenting
Path to Market
Entrepreneurial thinking Strategic thinking Design Thinking Forecasting
QUALITY OF IDEA
INNOVATION FLOW
Observation Questioning
FOCUS
WHATS NEXT
SCAMMPER
Minimize
Put to other use Eliminate Reverse
All data generated related to the discovery research will be available in the open for collaborative input
Driven by three key parameters OPEN DEVELOPMENT , OPEN ACCESS & OPEN SOURCE
Was successfully used in the Human Genome Project , to understand the mechanics of Proteins , by the IT Industry , Web Technology , etc.
BENEFITS
Bringing together the best available minds to tackle extremely challenging diseases. Speed of innovation Risk sharing Affordability
ISSUES
Who will fund the project and how much ? Who will lead the project ? Who will coordinate the project and find talents ? Who will take it through clinical development and regulatory approval process ?
June 2008 GLAXOSMITHKLINE released the GENOMIC PROFILING DATA for over 300 sets of cancer cell lines for THE NATIONAL CANCER INSTITUTES BIOINFORMATIC GRID
GLAXOSMITHKLINE in collaboration with EUROPEAN BIOINFORMATICS INSTITUTE and NATIONAL LIBRARY OF MEDICINE, USA has announced Open Invitation Strategy to discover innovative drugs for malaria
More than 2000 people have already registered for the project.
CONCLUSION
WHERE WE ARE
Limited no. of scientists associated with the innovator company ,work on a project for commercial security reasons. This consumes a lot of time and funds.
WHAT WE NEED
Scientists and volunteers across the globe will be able to contribute to the project . This will lead to reduction in R&D costs and will also save a lot of time and thereby leading to cheaper drugs.
THANK YOU
Q&A